Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the effect of intravenous polyspecific
immunoglobulin G (IVIG) compared with placebo (saline) on the patient-reported outcome
measure Physical Component Summary Score (PCS) of the SF-36 in patients with necrotizing soft
tissue infections (NSTI).
Phase:
Phase 2
Details
Lead Sponsor:
Anders Perner
Collaborator:
CSL Behring
Treatments:
Antibodies gamma-Globulins Immunoglobulin G Immunoglobulins Immunoglobulins, Intravenous Rho(D) Immune Globulin